Abstract
Hepatocellular carcinoma is one of the most prevalent forms of cancer throughout the globe. Despite this, therapy of HCC continues to be challenging because of the drawbacks of current treatments options. Lately, nanoparticulate based drug delivery systems have been employed for treatment of variety of cancers, including primary hepatic cancer. These nanocarriers can be tailored to meet the desired requirements on the basis of their size, charge, composition and surface properties. Following attachment to a targeting ligand, the deleterious and toxic effects associated with the drug could be reduced to a minimum, along with site selective delivery of antineoplastic agents. This article attempts to present a review of various nanoparticulate delivery systems which have been explored for the remedy of hepatocellular carcinoma.
Keywords: Asialoglycoprotein receptors, dendrimers, hepatocellular carcinoma, inorganic nanoparticles, Liposomes, magnetic nanoparticles, polymeric nanoparticles, solid lipid nanoparticles.
Current Cancer Therapy Reviews
Title:Nanoparticulate Drug Delivery Systems for Treatment of Hepatocellular Carcinoma
Volume: 10 Issue: 1
Author(s): Shruti S. Shrikhande, Darshana S. Jain, Rajani B. Athawale and Amrita N. Bajaj
Affiliation:
Keywords: Asialoglycoprotein receptors, dendrimers, hepatocellular carcinoma, inorganic nanoparticles, Liposomes, magnetic nanoparticles, polymeric nanoparticles, solid lipid nanoparticles.
Abstract: Hepatocellular carcinoma is one of the most prevalent forms of cancer throughout the globe. Despite this, therapy of HCC continues to be challenging because of the drawbacks of current treatments options. Lately, nanoparticulate based drug delivery systems have been employed for treatment of variety of cancers, including primary hepatic cancer. These nanocarriers can be tailored to meet the desired requirements on the basis of their size, charge, composition and surface properties. Following attachment to a targeting ligand, the deleterious and toxic effects associated with the drug could be reduced to a minimum, along with site selective delivery of antineoplastic agents. This article attempts to present a review of various nanoparticulate delivery systems which have been explored for the remedy of hepatocellular carcinoma.
Export Options
About this article
Cite this article as:
Shrikhande S. Shruti, Jain S. Darshana, Athawale B. Rajani and Bajaj N. Amrita, Nanoparticulate Drug Delivery Systems for Treatment of Hepatocellular Carcinoma, Current Cancer Therapy Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/157339471001140815151936
DOI https://dx.doi.org/10.2174/157339471001140815151936 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy
Current Drug Targets FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Targeted Therapies in Combination with Radiotherapy in Oesophageal and Gastroesophageal Carcinoma
Current Medicinal Chemistry Guggulsterone for Chemoprevention of Cancer
Current Pharmaceutical Design Computational Prediction of RNA Editing Sites: Successes and Challenges Ahead
Current Bioinformatics Pharmacology and Therapeutic Applications of Enediyne Antitumor Antibiotics
Current Molecular Pharmacology Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
Clinical Cancer Drugs Mind-Body Therapies and Osteoarthritis of the Knee
Current Rheumatology Reviews The Application of Pre-clinical Animal Models to Optimise Nanoparticulate Drug Delivery for Hepatocellular Carcinoma
Pharmaceutical Nanotechnology Cyclophilin A as a Target of Cisplatin Chemosensitizers
Current Cancer Drug Targets Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease
Current Diabetes Reviews Clinical and Genetic Features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) Syndrome
Current Molecular Medicine Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3<sup>-/-</sup> Mouse Fetuses
MicroRNA Protein Arginine Methyltransferase 1 and its Dynamic Regulation Associated with Cellular Processes and Diseases
Protein & Peptide Letters Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Therapeutic Potential of Alpinia officinarum
Mini-Reviews in Medicinal Chemistry Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
Current Vascular Pharmacology Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer
Current Genomics